Showing results (121-130 of 492) with videos related to

Sort By:
Pageof 50
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2008
Stopping a trial early in oncology: for patients or for industry?F Trotta, G Apolone, S Garattini, et al.
Pharmacology|January 1, 1986
1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and ratS Caccia, I Conti, G Viganò, et al.
Appetite|February 1, 1988
Disposition of D-fenfluramine in lean and obese ratsC Fracasso, G Guiso, S Garattini, et al.
European Journal of Pharmacology|January 14, 1986
d- and l-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the ratR Invernizzi, C Berettera, S Garattini, et al.
British Journal of Cancer|September 2, 2005
Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressuresG Apolone, R Joppi, V Bertele', et al.
Neuropsychobiology|January 1, 1981
Neurochemical correlates of muricidal behavior in ratsL Valzelli, S Garattini, S Bernasconi, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Low-dose neuroleptic therapy and relapse in schizophrenia: meta-analysis of randomized controlled trialsC Barbui, B Saraceno, A Liberati, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Single and multiple dose pharmacokinetics of etizolam in healthy subjectsC Fracasso, S Confalonieri, S Garattini, et al.
Neurochemistry International|May 22, 2010
Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotoninT Mennini, E Borroni, R Samanin, et al.
Psychopharmacology|January 1, 1990
Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the ratS Caccia, M Cappi, C Fracasso, et al.
Pageof 50